Mebea Aklilu

Mebea Aklilu

Hematology | Oncology

900 W Nelson St Ground Fl
Chicago, IL 60657

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer

Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: November 22, 2016

A brief yoga intervention implemented during chemotherapy: A randomized controlled pilot study.

A brief yoga intervention implemented during chemotherapy: A randomized controlled pilot study.

Journal: Complementary therapies in medicine

Published: March 16, 2016

Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.

Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.

Journal: Cancer

Published: February 29, 2016

Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer.

Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer.

Journal: Journal of gastrointestinal cancer

Published: January 24, 2014

Oncologic management of hereditary colorectal cancer.

Oncologic management of hereditary colorectal cancer.

Journal: Clinics in colon and rectal surgery

Published: June 05, 2013

A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.

A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.

Journal: Annals of surgery

Published: May 10, 2013

Optimal timing of systemic therapy in resectable colorectal liver metastases.

Optimal timing of systemic therapy in resectable colorectal liver metastases.

Journal: The American surgeon

Published: April 12, 2013

A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.

A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.

Journal: Journal for immunotherapy of cancer

Published: January 01, 2013

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomas.

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomas.

Journal: BMC cancer

Published: May 02, 2012

A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinoma.

A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinoma.

Journal: American journal of clinical oncology

Published: May 02, 2012

The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery.

The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery.

Journal: Journal of neurosurgery

Published: March 06, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026